We are glad to report that the Association of University Technology Managers issued COVID-19 Licensing Guidelines to favor the rapid uptake of COVID-19 related technologies to help solve the emergency.
Here are the Licensing Guidelines:
- Technology transfer accelerates innovations that impact society and promotes the broad distribution of public health solutions. We encourage intellectual property (IP) owners to adopt a COVID-19 licensing strategy that facilitates rapid pandemic response by licensees and to make the execution of associated transactions a top priority.
- For most technologies, where legally possible, this strategy is best accomplished by adopting time-limited, non-exclusive royalty-free licenses, in exchange for the licensees’ commitment to rapidly make and broadly distribute products and services to prevent, diagnose, treat and contain COVID-19 and protect healthcare workers during the pandemic (as defined by the World Health Organization).
- Licenses may subsequently convert to a more typical commercial license as appropriate. Licenses must also preserve the licensor’s freedom to publish and use the intellectual property for teaching and research.
The news is available on the AUTM’s website here.
We encourage public research institutions even outside the United States to act proactively to promote licensing of IP that can be used to combat the emergency.